Home › Archive for Keine Kategorie
Blog Archives

Wo sich Porträtfotos mit Genetik und KI treffen

Posted on by by Posted in In der Presse, In der Zukunft, Keine Kategorie, Thasso Post, Theragenomische Medizin No Comments ↓

13. Juni 2019 – Das ist einfach faszinierende Wissenschaft und Medizin. Die Forscher testen neuronale Netzewerke, die automatisch Porträtfotos mit genetischen und phänotypischen Patientendaten kombinieren, um mit Hilfe der künstlichen Intelligenz (KI) eine endgültige Diagnose erblich bedingter seltener Krankheiten zu erhalten. In einer im Journal of Genetics in Medicine veröffentlichten Studie mit 679 Patienten mit 105 seltenen Krankheiten hat ein interdisziplinäres Wissenschaftlerteam gezeigt,

…

Read more ›

Tags: , , , , , , , , , , ,

Iberogast: Pharmafirmen wie Autobauer. Täuschung der Kunden und Patienten für Profit

Posted on by by Posted in Keine Kategorie No Comments ↓

20. Oktober 2018 – Das in der traditionellen chinesischen Medizin und in der Naturheilkunde mit verschiedenen therapeutischen Wirkungen assoziierte Schöllkraut hat eine potenziell lebertoxische Wirkung. Aufgrund dieser Lebertoxizität von Schöllkraut wurde bereits 2008 allen Phytopharmaka mit einer Tagesdosis von mehr als 2,5 mg Chelidonium-Gesamtalkaloiden die Zulassung entzogen.

…

Read more ›

Tags: , , , , ,

Immunvermittelte nekrostisierende Myopathie: Eine seltene, jedoch bedrohliche Nebenwirkung unter Statin-Therapie

Posted on by by Posted in Keine Kategorie No Comments ↓

13. November 2015 – In den letzten Jahren wurden Statine (HMG-CoA-Reduktasehemmer) als ein möglicher Auslöser der seltenen immunvermittelten nekrotisierenden Myopathie (englisch als immune-mediated necrotising myopathy (IMNM) bezeichnet) identifiziert.

Swissmedic (Das Schweizerische Heilmittelinstitut) hat dazu am 21. Oktober 2015 eine sogenannte HPC (Health Profesional Communication) veröffentlicht.

…

Read more ›

Tags: , , , , , , ,

Rodapitant (Varubi) als eine neue Behandlung für Übelkeit und Erbrechen nach Chemotherapie zugelassen

Posted on by by Posted in Keine Kategorie No Comments ↓

2. September 2015 – phase die US Food and Drug Administration zugelassenen Rodapitant (Varubi) um zu vermeiden verzögert, Chemotherapie-induzierter Übelkeit und Erbrechen (Erbrechen). Rodapitant (Varubi) wird bei Erwachsenen in Kombination mit anderen Drogen (brechreizhemmende Agenten), die Übelkeit zu verhindern genehmigt und Erbrechen im Zusammenhang mit aus- und wiederholen-Kurse von Erbrochenem-induzierende (emetogenen und hoch emetogenen) Krebs-Chemotherapie.

…

Read more ›


Droge-Sicherheit-Kommunikation: DPP-4-Inhibitoren für Typ 2-Diabetes können schwere Gelenkschmerzen verursachen.

Posted on by by Posted in Keine Kategorie No Comments ↓

29. August 2015 – dies immerhin also gute Nachrichten für Typ-2-Diabetikern über DPP-4-Hemmer Medikamente möglicherweise nicht. Der amerikanischen Food and Drug Administration (FDA) warnt, dass die pharmakologisch wirksamen Bestandteile (PAI) Sitagliptin, Saxagliptin Linagliptin und Alogliptin mit Typ 2 Diabetes Medikamente Gelenkschmerzen verursachen können, die schwere und behindernden sein können.  

…

Read more ›


A potentially life-saving drug safety communication: FDA strengthens warning of increased chance of heart attack or stroke on non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs)

Posted on by by Posted in Keine Kategorie No Comments ↓

July 15, 2015 – This post comes directly from FDA, and it may not only be live-saving information for patients in the US, but all over the world, including the Africa’s, Europe, and Asia. 

The ISSUE: FDA is strengthening an existing drug label warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack or stroke.

…

Read more ›


Cangrelor (Kengreal) a newly approved antiplatelet drug used during PCI heart procedure

Posted on by by Posted in Keine Kategorie, New Drug Approval, Thasso Post, Theragenomic Medicine No Comments ↓

June 26, 2015 –  The following is good news for patients who will need percutaneous coronary intervention (PCI), however, bleeding problems are not completely resolved. But see for yourself.

The U.S. Food and Drug Administration just approved Cangrelor (Kengreal), an intravenous antiplatelet drug that prevents formation of harmful blood clots in the coronary arteries,

…

Read more ›

Tags: , , , ,

Eliglustat [Cerdelga] approved for the treatment of a form of Gaucher Disease

Posted on by by Posted in Keine Kategorie No Comments ↓

August 22. 2014 – On August 19, 2014, the U.S. Food and Drug Administration approved Cerdelga (eliglustat) for the long-term treatment of adult patients with the Type 1 form of Gaucher disease, a rare genetic disorder.

Gaucher disease occurs in people who do not produce enough of an enzyme called glucocerebrosidase.

…

Read more ›


FDA approves first non-invasive DNA screening test for colorectal cancer

Posted on by by Posted in Diagnostic, Keine Kategorie No Comments ↓

August 11. 2014 – The U.S. Food and Drug Administration today approved Cologuard, the first stool-based colorectal screening test that detects the presence of red blood cells and DNA mutations that may indicate the presence of certain kinds of abnormal growths that may be cancers such as colon cancer or precursors to cancer.

…

Read more ›

Tags: , , , ,

Genetic Trigger Discovered For Most Common Form of Mental Disability and Autism

Posted on by by Posted in Keine Kategorie, New Research, On The Horizon, Personalized Medicine, Thasso Post No Comments ↓

March 08, 1014 – The following article just appeared in PsyBlog and provides highly interesting reading in relation to newly discovered molecular mechanisms in the etiology of (possibly individualized) disease predispositions. Very exciting.

The most common form of intellectual disability is caused by a mechanism which shuts of an associated gene,

…

Read more ›

Tags: , , , ,

thasso: spenden

thasso: zustände

thasso: kurzmitteilungen

thasso post: magazin

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

RSS random genetics

  • Mayo researchers recommend all women with breast cancer diagnosis under age 66 be offered genetic testing February 21, 2020
    A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among […]
  • Cross-talk between enzymes that read and correct recipes in the cookbook of life February 21, 2020
    DNA is the hereditary material in humans, a unique cookbook of who we are. This is where you'll find the answer as to why you have your specific eye and hair colour, or perhaps why you sunburn easily.
  • Study finds certain genetic tests not useful in predicting heart disease risk February 21, 2020
    A Polygenic Risk Score—a genetic assessment that doctors have hoped could predict coronary heart disease (CHD) in patients—has been found not to be a useful predictive biomarker for disease risk, according to a Vanderbilt study published in the Journal of the American Medical Association.
  • Major discovery in the genetics of Down syndrome February 21, 2020
    Researchers at CHU Sainte-Justine and Université de Montréal have discovered a new mechanism involved in the expression of Down syndrome, one of the main causes of intellectual disability and congenital heart defects in children. The study's findings were published today in Current Biology.
  • MicroRNA exhibit unexpected function in driving cancer February 20, 2020
    Researchers long thought that only one strand of a double-stranded microRNA can silence genes. Though recent evidence has challenged that dogma, it's unclear what the other strand does, and how the two may be involved in cancer. New research from Thomas Jefferson University has revealed that both strands of some microRNA coordinate to act on […]

RSS random science

  • Specific gut bacteria may be associated with pulmonary arterial hypertension February 24, 2020
    Researchers have found a specific bacterial profile in the gut of people with pulmonary arterial hypertension, a chronic and progressive disease that causes constriction of arteries in the lungs. The unique bacterial profile predicted pulmonary arterial hypertension with 83% accuracy.
  • Intensive behavioral therapy and liraglutide 3.0 mg show positive results for weight loss February 24, 2020
    Intensive behavioral therapy (IBT) combined with liraglutide 3.0 mg (Saxenda) can produce clinically-meaningful weight loss in patients who receive the treatment in predominantly primary care settings, according to a study published online in Obesity, the flagship journal of The Obesity Society. The study is the first multi-site evaluation of the efficacy of IBT based on […]
  • Study links physical activity to quality of life in African American cancer survivors February 24, 2020
    New research published in CANCER suggests that regular exercise may improve the well-being of African American cancer survivors, but most survivors do not meet current recommendations for physical activity.
  • Obesity embargo alert for March 2020 February 24, 2020
    All print, broadcast and online journalists who receive the Obesity embargo alert agree to abide by the embargo and may not publish, post, broadcast or distribute embargoed news releases or details of the embargoed studies before the embargo date and time.
  • Could this plaque identifying toothpaste prevent a heart attack or stroke? February 24, 2020
    For decades, researchers have suggested a link between oral health and inflammatory diseases affecting the entire body -- in particular, heart attacks and strokes. Results of a randomized pilot trial of Plaque HD®, the first toothpaste that identifies plaque so that it can be removed with directed brushing, showed that it produced a statistically significant […]
Top